Fesoterodine for the treatment of overactive bladder

被引：0
|
作者：
Belavic, Jennifer M. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr Presbyterian, Trauma Intens Care Unit, Pittsburgh, PA 15260 USA
来源：
NURSE PRACTITIONER | 2009年 / 34卷 / 08期
关键词：
D O I：
10.1097/01.NPR.0000358655.33692.99
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [1] Fesoterodine for the Treatment of Overactive Bladder
    Tzefos, Maria
    Dolder, Christian
    Olin, Jacqueline L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (12) : 1992 - 2000
  • [2] Role of fesoterodine in the treatment of overactive bladder
    Mansfield, Kylie J.
    [J]. RESEARCH AND REPORTS IN UROLOGY, 2010, 2 : 1 - 9
  • [3] Evaluation of fesoterodine fumarate for the treatment of an overactive bladder
    Mock, Stephen
    Dmochowski, Roger R.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1659 - 1666
  • [4] Comparison of solifenacin and fesoterodine in treatment of overactive bladder
    Ercan, Onder
    Kostu, Bulent
    Bakacak, Murat
    Aytac-Tohma, Yusuf
    Coskun, Bora
    Avci, Fazil
    Efe, Erkan
    [J]. SAUDI MEDICAL JOURNAL, 2015, 36 (10) : 1181 - 1185
  • [5] Fesoterodine (Toviaz) for Overactive Bladder
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1311): : 34 - 35
  • [6] Flexible dose fesoterodine in the treatment of overactive bladder (OAB)
    Tubaro, Andrea
    De Nunzio, Cosimo
    [J]. BJU INTERNATIONAL, 2013, 112 (03) : 281 - 282
  • [7] New Perspectives of Treatment With Fesoterodine Fumarate in Patients With Overactive Bladder
    Garcia-Baquero, R.
    Madurga, B.
    Garcia, M. V.
    Fernandez, M. A.
    Rosety, J. M.
    Alvarez-Ossorio, J. L.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (02): : 83 - 91
  • [8] Pharmacokinetic profile of fesoterodine, a novel antimuscarinic treatment for overactive bladder
    Malhotra, Bimal
    Wood, Nolan
    Guan, Zhonghong
    Gandelman, Kuan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 999 - 1000
  • [9] AN ECONOMIC EVALUATION OF FESOTERODINE IN THE TREATMENT OF OVERACTIVE BLADDER (OAB) IN KOREA
    Jo, C.
    Lee, S. J.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A200 - A200
  • [10] Fesoterodine, an advanced antimuscarinic for the treatment of overactive bladder: A safety update
    Cole, P
    [J]. DRUGS OF THE FUTURE, 2004, 29 (07) : 715 - 720
12345